Join us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multi-dimensional expansion to reach more patients through a rich pipeline of differentiated assets, led by VYVGART, our first-in-class neonatal Fc receptor blocker approved for the treatment of gMG, and with the potential to treat patients across dozens of severe autoimmune diseases. We are building a new kind of biotech company, one that maintains its roots as a science-based start-up and pushes our commitment to innovate across all corners of our business. We strive to inspire and grow our company, our partnerships, our science, and our people, because when we do, we deliver more for patients. As the HCP Experience Lead, you are accountable for the commercial success of VYVGART across multiple indications and Therapeutic Areas (TAs), delivering on the successful launch of our late-stage assets Empasiprubart, Adimanebart, and preparing the organization for future argenx products, across multiple indications and TAs. You will achieve this mission by leading the development and execution of an integrated HCP Commercial engagement strategy, empowering the HCP marketing team and field-facing teams and communities across the argenx ecosystem. Provide key strategic advice to multiple Indication Strategy Teams and may serve as a Commercialization Asset Strategy Lead across multiple TAs. You will be partnering closely with our Development and Global Commercialization Teams to enable successful launches across our long horizon vision.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level